APTUS PHARMA LIMITED IPO
APTUS PHARMA LIMITED was a SME IPO, offered at ₹26–₹28 per share. The issue was subscribed 20.79× overall (QIBs 1.24×, NIIs 21.51×, retail 31.48×). It listed on 30 Sep 2025 at ₹32 and closed its first day at ₹34, a listing gain of +21.2% versus the ₹28 issue price. It now trades around ₹453 (+1519.5% versus the issue price).
Frequently asked questions
- How many times was the APTUS PHARMA LIMITED IPO subscribed?
- The APTUS PHARMA LIMITED IPO was subscribed 20.79× overall — 1.24× in the QIB category, 21.51× among non-institutional investors, 31.48× in retail.
- What were the APTUS PHARMA LIMITED IPO listing gains?
- APTUS PHARMA LIMITED listed on 30 Sep 2025 at ₹32, closing its first day at ₹34 — a listing gain of +21.2% versus the ₹28 issue price.
- What were the retail allotment odds for the APTUS PHARMA LIMITED IPO?
- Retail was subscribed 31.48×, so a single-lot application had roughly a 3.2% chance of allotment (about 1 in 31), and allotment was finalised on 26 Sep 2025.
- What was the price band and lot size of the APTUS PHARMA LIMITED IPO?
- The price band was ₹26–₹28 per share.